Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Lawrence Blonde, Michelle A. Baron, Rong Zhou & Mary Ann Banerji. (2014) Efficacy and Risk of Hypoglycemia With Use of Insulin Glargine or Comparators in Patients With Cardiovascular Risk Factors. Postgraduate Medicine 126:3, pages 172-189.
Read now
Read now
Raffaella Arnò, Luciana Bastagli & Cristian Martignani. (2013) Poor Glycaemic Control and Arrhythmias. Endocrine Research 38:4, pages 206-214.
Read now
Read now
Christina Voulgari, Dimitrios Papadogiannis & Nicholas Tentolouris. (2010) Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vascular Health and Risk Management 6, pages 883-903.
Read now
Read now
Jean-Pierre Le Floch. (2010) Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics. Diabetes, Metabolic Syndrome and Obesity 3, pages 197-213.
Read now
Read now
Peter A. McCullough & Thomas A. Verrill. (2010) Cardiorenal Interaction: Appropriate Treatment of Cardiovascular Risk Factors to Improve Outcomes in Chronic Kidney Disease. Postgraduate Medicine 122:2, pages 25-34.
Read now
Read now
Articles from other publishers (20)
Mª José Carrera, Pedro Moliner, Gemma Llauradó, Cristina Enjuanes, Laura Conangla, Juan-José Chillarón, Silvia Ballesta, Elisenda Climent, Josep Comín-Colet & Juana-Antonia Flores-Le Roux. (2021) Prognostic Value of the Acute-to-Chronic Glycemic Ratio at Admission in Heart Failure: A Prospective Study. Journal of Clinical Medicine 11:1, pages 6.
Crossref
Crossref
Clement Lo, Tadashi Toyama, Ying Wang, Jin Lin, Yoichiro Hirakawa, Min Jun, Alan Cass, Carmel M Hawley, Helen Pilmore, Sunil V Badve, Vlado Perkovic & Sophia Zoungas. (2018) Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Marinella Ruospo, Valeria M Saglimbene, Suetonia C Palmer, Salvatore De Cosmo, Antonio Pacilli, Olga Lamacchia, Mauro Cignarelli, Paola Fioretto, Mariacristina Vecchio, Jonathan C Craig & Giovanni FM Strippoli. (2017) Glucose targets for preventing diabetic kidney disease and its progression. Cochrane Database of Systematic Reviews 2017:6.
Crossref
Crossref
Carmine Gazzaruso, Mariangela Fodaro & Adriana Coppola. (2016) Structured therapeutic education in diabetes: is it time to re-write the chapter on the prevention of diabetic complications?. Endocrine 53:2, pages 347-349.
Crossref
Crossref
Simone Theilade, Peter Rossing, Jesper Eugen-Olsen, Jan S Jensen & Magnus T Jensen. (2016) suPAR level is associated with myocardial impairment assessed with advanced echocardiography in patients with type 1 diabetes with normal ejection fraction and without known heart disease or end-stage renal disease. European Journal of Endocrinology 174:6, pages 745-753.
Crossref
Crossref
K. M. Fox, Y. Wu, J. Kim & S. Grandy. (2015) Cardiovascular event rates and healthcare resource utilisation among high-risk adults with type 2 diabetes mellitus in a large population-based study. International Journal of Clinical Practice 69:2, pages 218-227.
Crossref
Crossref
Steffani R. Bailey, Jean P. O’Malley, Rachel Gold, John Heintzman, Miguel Marino & Jennifer E. DeVoe. (2015) Receipt of Diabetes Preventive Services Differs by Insurance Status at Visit. American Journal of Preventive Medicine 48:2, pages 229-233.
Crossref
Crossref
Andrew A. Monte, Kennon J. Heard, Jason A. Hoppe, Vasilis Vasiliou & Frank J. Gonzalez. (2015) The accuracy of self-reported drug ingestion histories in emergency department patients. The Journal of Clinical Pharmacology 55:1, pages 33-38.
Crossref
Crossref
David Grembowski, James D. Ralston & Melissa L. Anderson. (2014) Hemoglobin A1c, comorbid conditions and all-cause mortality in older patients with diabetes: A retrospective 9-year cohort study. Diabetes Research and Clinical Practice 106:2, pages 373-382.
Crossref
Crossref
Martin Füchtenbusch & Michael Hummel. (2014) Frühe Insulintherapie: gibt es hierfür gute Gründe?. MMW - Fortschritte der Medizin 156:9, pages 37-41.
Crossref
Crossref
A. Vittorino Gaddi, D. Benedetto, F. Capello, C. Di Pietro, E. Cinconze, E. Rossi, V. De Sando, M. Cevenini & G. D'Alò. (2014) Oral antidiabetic therapy in a large Italian sample: drug supply and compliance for different therapeutic regimens. Public Health 128:1, pages 70-76.
Crossref
Crossref
Nada Oršolić, Damir Sirovina, Goran Gajski, Vera Garaj-Vrhovac, Maja Jazvinšćak Jembrek & Ivan Kosalec. (2013) Assessment of DNA damage and lipid peroxidation in diabetic mice: Effects of propolis and epigallocatechin gallate (EGCG). Mutation Research/Genetic Toxicology and Environmental Mutagenesis 757:1, pages 36-44.
Crossref
Crossref
Endre Szigethy, Zoltán Jancsó, Csaba Móczár, István Ilyés, Eszter Kovács, László Róbert Kolozsvári & Imre Rurik. (2013) Primary care of patients with high cardiovascular riskErstversorgung von Patienten mit hohem kardiovaskulärem Risiko. Wiener klinische Wochenschrift 125:13-14, pages 371-380.
Crossref
Crossref
Tom Seijkens, Pascal Kusters, David Engel & Esther Lutgens. (2012) CD40–CD40L: Linking pancreatic, adipose tissue and vascular inflammation in type 2 diabetes and its complications. Diabetes and Vascular Disease Research 10:2, pages 115-122.
Crossref
Crossref
S. Inaba, H. Okayama, J.-i. Funada, H. Higashi, M. Saito, T. Yoshii, G. Hiasa, T. Sumimoto, Y. Takata, K. Nishimura, K. Inoue, A. Ogimoto & J. Higaki. (2012) Impact of type 2 diabetes on serial changes in tissue characteristics of coronary plaques: an integrated backscatter intravascular ultrasound analysis. European Heart Journal - Cardiovascular Imaging 13:9, pages 717-723.
Crossref
Crossref
Maggie N. Tillquist & Thomas M. Maddox. (2012) Update on Diabetic Cardiomyopathy: Inches Forward, Miles to Go. Current Diabetes Reports 12:3, pages 305-313.
Crossref
Crossref
Christine Chung, Sharif Ellozy, Michael L. Marin & Peter L. Faries. 2012. Diabetes and Peripheral Vascular Disease. Diabetes and Peripheral Vascular Disease
181
195
.
James H. O'Keefe, Mohammad Abuannadi, Carl J. Lavie & David S.H. Bell. (2011) Strategies for Optimizing Glycemic Control and Cardiovascular Prognosis in Patients With Type 2 Diabetes Mellitus. Mayo Clinic Proceedings 86:2, pages 128-138.
Crossref
Crossref
Xiaoxing Z. He. (2011) Diabetes Preventive Services and Policy Implications in the U.S.. Diabetes Care 34:1, pages 8-13.
Crossref
Crossref
Jean Doucet, Bernard Bauduceau & Patrice Queneau. (2010) Quels enjeux thérapeutiques chez la personne âgée diabétique ?. Bulletin de l'Académie Nationale de Médecine 194:4-5, pages 819-831.
Crossref
Crossref